Ignite Creation Date:
2024-05-05 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00189774
Status:
COMPLETED
Last Update Posted:
2008-03-13
First Post:
2005-09-13
Brief Title:
Nateglinide a Double Blind Add-on Study With Pioglitazone for Type 2 Diabetic Patients
Sponsor:
Organization:
Astellas Pharma Inc